Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 159,039 | 71,931 | 90,185 | 273,027 | 217,718 |
| Cost of Goods | 25,667 | 30,948 | 35,037 | 147,517 | 118,089 |
| Gross Profit | 133,372 | 40,983 | 55,148 | 125,510 | 99,629 |
| Operating Expenses | 162,294 | 137,063 | 137,837 | 162,175 | 258,948 |
| Operating Income | -28,255 | -95,132 | -82,652 | -36,148 | -159,230 |
| Interest Expense | 11,174 | 12,176 | 15,192 | 18,638 | 20,793 |
| Other Income | 2,372 | 4,536 | 62,702 | 23,334 | 26,090 |
| Pre-tax Income | -37,057 | -102,772 | -35,142 | -31,452 | -153,933 |
| Income Tax | 881 | -253 | -806 | 1,309 | 828 |
| Net Income Continuous | -37,938 | -102,519 | -34,336 | -32,761 | -154,761 |
| Net Income | $-37,938 | $-102,519 | $-34,336 | $-32,761 | $-154,761 |
| EPS Basic Total Ops | -6.00 | -16.64 | -5.55 | -5.40 | -25.79 |
| EPS Basic Continuous Ops | -6.05 | -16.57 | -5.57 | -5.35 | -25.84 |
| EPS Diluted Total Ops | -6.00 | -16.64 | -5.55 | -5.40 | -25.79 |
| EPS Diluted Continuous Ops | -6.05 | -16.57 | -5.57 | -5.35 | -25.84 |
| EBITDA(a) | $-11,704 | $-80,251 | $-60,163 | $-7,120 | $-125,721 |